PHARM.AS
Pharming Group N.V. News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 1,
"returned": 1,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "c4530aa3-39c7-45b4-ac1d-d7a2387b6465",
"title": "Genomenon Partners with Pharming to Advance APDS Diagnosis",
"description": "/PRNewswire-PRWeb/ -- Genomenon, a genomic intelligence company, has partnered with Pharming Group in an effort to make variant data on the PIK3CD and PIK3R1...",
"keywords": "Genomenon",
"snippet": "\"This partnership has the potential to enhance validation, diagnostic developments, and patient identification for precision medicine.\" Post this\n\nPharming has ...",
"url": "https://www.prweb.com/releases/genomenon-partners-with-pharming-to-advance-apds-diagnosis-302133979.html",
"image_url": "https://mma.prnewswire.com/media/2401797/Genomenon_Blue_Stacked_2024_500x300.jpg?p=facebook",
"language": "en",
"published_at": "2024-05-02T10:00:00.000000Z",
"source": "prweb.com",
"relevance_score": null,
"entities": [
{
"symbol": "PHARM.AS",
"name": "Pharming Group N.V.",
"exchange": null,
"exchange_long": null,
"country": "nl",
"type": "equity",
"industry": "Healthcare",
"match_score": 48.496582,
"sentiment_score": 0.4588,
"highlights": [
{
"highlight": "About <em>Pharming</em> <em>Group</em> <em>N.V</em>\n\n<em>Pharming</em> <em>Group</em> <em>N.V</em>. (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases.",
"sentiment": 0.4588,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "PHARM.AS",
"total_documents": 1,
"sentiment_avg": 0.45879998803138733
}
]
}
Other details
Exchange
- Euronext Amsterdam
- equity
- Healthcare
- nl